RR&D Research Career Scientist Award Application

RR

基本信息

项目摘要

The overarching goals of Dr. Myers' research program are to apply exercise therapy and lifestyle intervention to help restore function, reduce disability, and reduce health care costs in Veterans with chronic disease. These areas include diagnostic and prognostic applications of cardiopulmonary exercise testing, and the physiologic effects of multidisciplinary rehabilitation programs in patients with chronic heart failure, coronary artery disease, abdominal aortic aneurysm disease, spinal cord injury, mild cognitive impairment, and chronic renal failure. He is currently PI on two VA RR&D projects, one entitled, “PCI Alternative using Sustained Exercise (PAUSE),” and the other entitled, “Exercise to Prevent Muscle Mass and Functional Loss in Elderly Dialysis Patients (PERFECT).” The PAUSE project extends his work on the clinical applications of rehabilitation in patients with cardiovascular disease. Cardiovascular disease remains the leading cause of mortality in Veterans, and in addition to assessing the physiologic effects of exercise and lifestyle intervention as an alternative to invasive treatment of coronary artery disease, the study addresses the cost effectiveness of non-invasive (lifestyle intervention) vs. invasive (coronary stenting) strategies. The PERFECT trial focuses on the effects of exercise therapy on muscle mass and function in chronic renal failure. Renal failure is an important condition in the VA because of its cost (estimated to be the second most costly condition in the VA), its prevalence (estimated to be 34% higher than the general population), and its devastating effects on physical function and disability. Dr. Myers current work also includes three funded projects involving the effects of exercise therapy in patients with mild cognitive impairment. These studies are designed to evaluate the effectiveness of exercise augmentation strategies along with cognitive training interventions to improve cognitive performance in older Veterans with mild cognitive impairment. Dr. Myers initiated and manages a relational database of clinical, angiographic, and exercise test responses dating back to 1987. This database has been a resource for answering many epidemiologic questions affecting Veterans (termed the Veterans Exercise Testing Study, or VETS). The VETS study is an ongoing, prospective evaluation of Veteran subjects referred for exercise testing for clinical reasons, designed to address exercise test, clinical, and lifestyle factors and their association with health outcomes. Studies from the VETS cohort have addressed the prevalence, temporal trends, and health care costs associated with statin use, obesity, chronic heart failure, cardiac rhythm abnormalities and other chronic conditions, and how these conditions are influenced by fitness and physical activity patterns. Analyses from the VETS cohort have influenced guidelines on exercise testing from major health organizations. He coordinates two other national data bases, a 7-center heart failure cardiopulmonary exercise test consortium, and the AHA/CDC- sponsored Fitness Registry and the Importance of Exercise: A National Data Base (FRIEND). The FRIEND initiative is designed to develop a national fitness registry in order to better inform clinicians and the public about the importance of physical activity and fitness and their role in the prevention of chronic disease. As Co-PI, he recently completed a 6-year NIH-funded Specialized Center of Clinically-Oriented Research (SCCOR) project entitled, “Exercise Therapy in Abdominal Aortic Aneurysm Disease.” The SCCOR program was initiated by the National Heart, Lung, and Blood Institute to foster multidisciplinary research on clinically relevant topics facilitating basic science findings to be more rapidly applied to clinical problems, with an emphasis on prevention, diagnosis, and treatment of a particular disease. This project has particular relevance to Veterans, since it has been shown that the prevalence of abdominal aortic aneurism disease in Veterans >60 years is 14.3%, with potentially lethal consequences if the disease is not treated.
迈尔斯博士的研究计划的首要目标是将运动疗法和生活方式 干预,以帮助恢复功能,减少残疾,并减少慢性退伍军人的医疗保健费用 疾病这些领域包括心肺运动试验的诊断和预后应用, 以及多学科康复计划对慢性心力衰竭患者的生理影响, 冠状动脉疾病,腹主动脉瘤疾病,脊髓损伤,轻度认知障碍, 和慢性肾衰竭他目前是两个VA RR&D项目的PI,一个名为“PCI替代使用”, 持续运动(暂停),”和其他题为“运动,以防止肌肉质量和功能 老年透析患者的损失(完美)。PAUSE项目扩展了他在临床上的工作 康复在心血管疾病患者中的应用。心血管疾病仍然是 退伍军人死亡的主要原因,除了评估运动的生理效应, 生活方式干预作为冠状动脉疾病侵入性治疗的替代方法, 非侵入性(生活方式干预)与侵入性(冠状动脉支架)策略的成本效益。的 PERFECT试验关注运动疗法对慢性肾功能衰竭患者肌肉质量和功能的影响。 失败肾功能衰竭是VA的一个重要条件,因为它的成本(估计是第二个 VA中最昂贵的条件),其患病率(估计比一般人群高34%), 及其对身体功能和残疾的毁灭性影响。迈尔斯博士目前的工作还包括三个 资助的项目涉及运动疗法对轻度认知障碍患者的影响。这些 研究旨在评估运动增强策略的有效性,沿着认知 训练干预,以改善轻度认知障碍的老年退伍军人的认知表现。 博士迈尔斯发起并管理一个临床、血管造影和运动试验反应的关系数据库 可以追溯到1987年该数据库已成为回答许多流行病学问题的资源 影响退伍军人(称为退伍军人运动测试研究,或兽医)。兽医研究是一项正在进行的, 对因临床原因转诊进行运动试验的退伍军人受试者进行前瞻性评价,旨在 解决运动试验,临床和生活方式因素及其与健康结果的关联。研究从 VETS队列研究了与以下疾病相关的患病率、时间趋势和卫生保健费用: 他汀类药物使用、肥胖、慢性心力衰竭、心律异常和其他慢性疾病,以及如何 这些条件受到健康和身体活动模式的影响。VETS队列分析 影响了主要健康组织的运动测试指南。他协调了另外两个 国家数据库,7个中心的心力衰竭心肺运动试验联盟,以及AHA/CDC- 健身注册和锻炼的重要性:国家数据库(FRIEND)。朋友 该倡议旨在建立一个全国健身登记册,以便更好地告知临床医生和公众 有关体育活动和健身的重要性及其在预防慢性病方面的作用。作为 他最近完成了一个为期6年的NIH资助的临床导向研究专业中心 (SCCOR)项目,题为“腹主动脉瘤疾病的运动疗法”。SCCOR计划 是由国家心脏,肺和血液研究所发起的,以促进临床上的多学科研究。 相关主题促进基础科学发现更快地应用于临床问题, 强调预防,诊断和治疗特定疾病。该项目特别 与退伍军人的相关性,因为它已被证明,腹主动脉粥样硬化疾病的患病率, >60岁的退伍军人占14.3%,如果不治疗,可能会造成致命后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan N. Myers其他文献

CHANGES IN CARDIORESPIRATORY FITNESS STATUS REFLECT CHANGES IN CHRONIC HEART FAILURE INCIDENCE
  • DOI:
    10.1016/s0735-1097(23)02681-5
  • 发表时间:
    2023-03-07
  • 期刊:
  • 影响因子:
  • 作者:
    Andreas E. Pittaras;Peter F. Kokkinos;Michail Doumas;Charalambos Grassos;Angelique Faselis;Belinda Gorsuch;Jonathan N. Myers
  • 通讯作者:
    Jonathan N. Myers
PEDSQL, EXERCISE CAPACITY, AND ENDOTHELIAL FUNCTION IN PEDIATRIC FONTAN PATIENTS
  • DOI:
    10.1016/s0735-1097(24)04397-3
  • 发表时间:
    2024-04-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jerin Jose;Daniel Bernstein;Latha P. Palaniappan;Mary Leonard;JIN LONG;Manisha Desai;Mavis Lui;Tania Davila;John P. Cooke;Inger L. Olson;Jonathan N. Myers;Lauren Schneider;Elif Seda Selamet Tierney
  • 通讯作者:
    Elif Seda Selamet Tierney
RESTING HEART RATE AND MORTALITY RISK IN HYPERTENSIVE PATIENTS WITH NO ATRIAL FIBRILLATION, ADJUSTED FOR CARDIORESPIRATORY FITNESS AND B-BLOCKADE
在未患有心房颤动且经心肺适能和β受体阻滞剂调整的高血压患者中,静息心率与死亡风险
  • DOI:
    10.1016/s0735-1097(25)01024-1
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    22.300
  • 作者:
    Andreas E. Pittaras;Peter F. Kokkinos;Charles Faselis;Charalampos Grassos;Athanasios J. Manolis;Michail Doumas;Carl J. Lavie;Jonathan N. Myers
  • 通讯作者:
    Jonathan N. Myers
THE EFFECT OF MAVACAMTEN ON CARDIOPULMONARY EXERCISE TESTING PERFORMANCE OF PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN EXPLORER-HCM
  • DOI:
    10.1016/s0735-1097(22)01228-1
  • 发表时间:
    2022-03-08
  • 期刊:
  • 影响因子:
  • 作者:
    Matthew Thomas Wheeler;Iacopo Olivotto;Perry M. Elliott;Sara Saberi;Anjali Tiku Owens;Mathew S. Maurer;Ahmad Masri;Amy Sehnert;Jay Edelberg;Wanying Li;Victoria Florea;Rajeev Malhotra;Andrew Wang;Artur Oreziak;Daniel Jacoby;Jonathan N. Myers
  • 通讯作者:
    Jonathan N. Myers
二光子顕微鏡を用いたニコチン性アセチルコリン受容体アゴニストによる脳機能障害の検出
双光子显微镜检测烟碱乙酰胆碱受体激动剂引起的脑功能障碍
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Robert A. Sloan;Marco Visentini Scarzanella;Susumu S. Sawada;Xuemei Sui;Jonathan N. Myers;Steven N. Blair;平井杏梨,杉尾翔太,Collins Nimako,中山翔太,加藤恵介,高橋圭介,有薗幸司,平野哲史,星 信彦,藤岡一俊,平久美子,石塚真由美,和氣弘明,池中良徳
  • 通讯作者:
    平井杏梨,杉尾翔太,Collins Nimako,中山翔太,加藤恵介,高橋圭介,有薗幸司,平野哲史,星 信彦,藤岡一俊,平久美子,石塚真由美,和氣弘明,池中良徳

Jonathan N. Myers的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan N. Myers', 18)}}的其他基金

RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10553090
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10311474
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Exercise to Prevent Muscle Mass and Functional Loss in Elderly Dialysis Patients
通过运动预防老年透析患者的肌肉质量和功能丧失
  • 批准号:
    8586711
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Exercise to Prevent Muscle Mass and Functional Loss in Elderly Dialysis Patients
通过运动预防老年透析患者的肌肉质量和功能丧失
  • 批准号:
    9016449
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Establishment of human abdominal aortic aneurysm wall strength prediction model using Ex Vivo Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging
利用Ex Vivo超顺磁性氧化铁建立人体腹主动脉瘤壁强度预测模型
  • 批准号:
    23K08226
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
  • 批准号:
    10733477
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Extracellular Vesicle Delivery System for Treatment of Abdominal Aortic Aneurysm
细胞外囊泡递送系统治疗腹主动脉瘤
  • 批准号:
    10751123
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
I-Corps: A Clinical Decision Support Tool to Manage Abdominal Aortic Aneurysm Patients
I-Corps:管理腹主动脉瘤患者的临床决策支持工具
  • 批准号:
    2318665
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Atherosclerosis drives arterial damage and abdominal aortic aneurysm formation and rupture
动脉粥样硬化导致动脉损伤和腹主动脉瘤形成和破裂
  • 批准号:
    483212
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Development of phospholipid-based nanotherapeutics for treating abdominal aortic aneurysm
开发基于磷脂的纳米疗法治疗腹主动脉瘤
  • 批准号:
    10749980
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growth
PCSK9 抑制对腹主动脉瘤病理学和生长的影响
  • 批准号:
    10566800
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
The Role of Amino Acid Starvation Response Kinase GCN2 in Abdominal Aortic Aneurysm
氨基酸饥饿反应激酶 GCN2 在腹主动脉瘤中的作用
  • 批准号:
    10584543
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Atherosclerotic process drives arterial damage, abdominal aortic aneurysm formation, and rupture
动脉粥样硬化过程导致动脉损伤、腹主动脉瘤形成和破裂
  • 批准号:
    477264
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Endovascular Orifice Detection (EOrD) Device for in situ Fenestration of Abdominal Aortic Aneurysm
用于腹主动脉瘤原位开窗的血管内孔口检测 (EOrD) 装置
  • 批准号:
    10453104
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了